An animal model of schizophrenia based on chronic LSD administration: Old idea, new results
- 1 September 2011
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 61 (3), 503-512
- https://doi.org/10.1016/j.neuropharm.2011.02.006
Abstract
No abstract availableKeywords
Funding Information
- NIH
- NIMH (MH083689)
- NIDA (DA02189)
This publication has 32 references indexed in Scilit:
- Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptorsInternational Journal of Neuropsychopharmacology, 2010
- Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of actionPharmacology Biochemistry and Behavior, 2007
- Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase‐1, C/EBP‐β and ILAD‐1, a novel gene with homology to arrestinsJournal of Neurochemistry, 2004
- HallucinogensPharmacology & Therapeutics, 2004
- Activation of Glutamate Neurotransmission in the Prefrontal Cortex Sustains the Motoric and Dopaminergic Effects of PhencyclidineNeuropsychopharmacology, 2002
- The Effects of Excitotoxic Hippocampal Lesions in Rats on Risperidone- and Olanzapine-Induced Locomotor SuppressionNeuropsychopharmacology, 2002
- A Single Dose of Lysergic Acid Diethylamide Influences Gene Expression Patterns within the Mammalian BrainNeuropsychopharmacology, 2002
- Dopamine D2 Receptor Occupancy Is a Common Mechanism Underlying Animal Models of Antipsychotics and Their Clinical EffectsNeuropsychopharmacology, 2001
- Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: A link between the glutamatergic and serotonergic hypotheses of schizophreniaLife Sciences, 2000
- Hallucinogenic drug research— if so, so what?: Symposium summary and commentaryPharmacology Biochemistry and Behavior, 1986